Search results
Found 10059 matches for
Researchers at the Kennedy Institute, part of NDORMS have repurposed the approved drug miglustat to successfully slow the progression of multiple myeloma.
Our DPhil students
Our world-leading translational science driven by exceptional DPhil students.